MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

+ + data and comment + +, page-12

  1. 1,363 Posts.
    re: + + phase iib trial commences + Gerry, how long do these trials take?

    Chart indicates support at $0.95 , might not get that low given this positive news.

    Big market cap given its trial stage, 216 mil!!

    Makes ept look cheap does it not?
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.